Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Knowledge-based analysis of multi-potent G-protein coupled receptors ligands.

Faure P, Dubus E, Ijjaali I, Morlière C, Barberan O, Petitet F.

Eur J Med Chem. 2010 Dec;45(12):5708-17. doi: 10.1016/j.ejmech.2010.09.027. Epub 2010 Sep 17.

PMID:
20933307
2.

Assessing the chemical diversity of an hsp90 database.

Audisio D, Messaoudi S, Ijjaali I, Dubus E, Petitet F, Peyrat JF, Brion JD, Alami M.

Eur J Med Chem. 2010 May;45(5):2000-9. doi: 10.1016/j.ejmech.2010.01.048. Epub 2010 Jan 28.

PMID:
20170986
3.

Drug repositioning using in silico compound profiling.

Dubus E, Ijjaali I, Barberan O, Petitet F.

Future Med Chem. 2009 Dec;1(9):1723-36. doi: 10.4155/fmc.09.123.

PMID:
21425988
4.

Virtual screening for cytochromes p450: successes of machine learning filters.

Burton J, Ijjaali I, Petitet F, Michel A, Vercauteren DP.

Comb Chem High Throughput Screen. 2009 May;12(4):369-82. Review.

PMID:
19442071
5.

Assessing the chemical and biological diversity of an ion channels knowledge database.

Ijjaali I, Dubus E, Bourinet E, Petitet F.

Channels (Austin). 2007 Jul-Aug;1(4):291-9. Epub 2007 Sep 28.

PMID:
18708748
6.

Ligand-based virtual screening to identify new T-type calcium channel blockers.

Ijjaali I, Barrere C, Nargeot J, Petitet F, Bourinet E.

Channels (Austin). 2007 Jul-Aug;1(4):300-4. Epub 2007 Sep 7.

PMID:
18708747
7.

Boosted regression trees, multivariate adaptive regression splines and their two-step combinations with multiple linear regression or partial least squares to predict blood-brain barrier passage: a case study.

Deconinck E, Zhang MH, Petitet F, Dubus E, Ijjaali I, Coomans D, Vander Heyden Y.

Anal Chim Acta. 2008 Feb 18;609(1):13-23. doi: 10.1016/j.aca.2007.12.033. Epub 2008 Jan 8.

PMID:
18243869
8.

Assessing potency of c-Jun N-terminal kinase 3 (JNK3) inhibitors using 2D molecular descriptors and binary QSAR methodology.

Ijjaali I, Petitet F, Dubus E, Barberan O, Michel A.

Bioorg Med Chem. 2007 Jun 15;15(12):4256-64. Epub 2007 Mar 24.

PMID:
17451961
9.

Development of an ADME and drug-drug interactions knowledge database for the acceleration of drug discovery and development.

Petitet F, Barberan O, Dubus E, Ijjaali I, Donlan M, Ollivier S, Michel A.

Expert Opin Drug Discov. 2006 Dec;1(7):737-51. doi: 10.1517/17460441.1.7.737.

PMID:
23495997
10.

Recursive partitioning for the prediction of cytochromes P450 2D6 and 1A2 inhibition: importance of the quality of the dataset.

Burton J, Ijjaali I, Barberan O, Petitet F, Vercauteren DP, Michel A.

J Med Chem. 2006 Oct 19;49(21):6231-40.

PMID:
17034129
11.

In silico classification of HERG channel blockers: a knowledge-based strategy.

Dubus E, Ijjaali I, Petitet F, Michel A.

ChemMedChem. 2006 Jun;1(6):622-30.

PMID:
16892402
12.

GPR55 as a new cannabinoid receptor: still a long way to prove it.

Petitet F, Donlan M, Michel A.

Chem Biol Drug Des. 2006 Mar;67(3):252-3. No abstract available.

PMID:
16611220
13.

Cannabinoid penetration into mouse brain as determined by ex vivo binding.

Petitet F, Jeantaud B, Bertrand P, Imperato A.

Eur J Pharmacol. 1999 Jun 25;374(3):417-21.

PMID:
10422786
14.

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Böhme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M.

Science. 1999 Jan 15;283(5400):401-4.

16.

Interaction of brain cannabinoid receptors with guanine nucleotide binding protein: a radioligand binding study.

Petitet F, Jeantaud B, Capet M, Doble A.

Biochem Pharmacol. 1997 Dec 1;54(11):1267-70.

PMID:
9416978
17.

Localization of presenilin-1 mRNA in rat brain.

Quarteronet D, Pradier L, Czech C, Delalonde L, Burgevin MC, Doble A, Petitet F.

Neuroreport. 1996 Nov 4;7(15-17):2587-91.

PMID:
8981428
18.

The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor.

Heuillet E, Petitet F, Mignani S, Malleron JL, Lavayre J, Néliat G, Doble A, Blanchard JC.

Eur J Pharmacol. 1996 Oct 24;314(1-2):229-33.

PMID:
8957240
19.

Biochemical and pharmacological characterization of cannabinoid binding sites using [3H]SR141716A.

Petitet F, Marin L, Doble A.

Neuroreport. 1996 Feb 29;7(3):789-92.

PMID:
8733746
20.

Effects of AMPA receptor modulators on the production of arachidonic acid from striatal neurons.

Petitet F, Blanchard JC, Doble A.

Eur J Pharmacol. 1995 Oct 15;291(2):143-51.

PMID:
8566164
21.
22.
23.

Differential localization of 3H-[Pro9]SP binding sites in the guinea pig and rat brain.

Saffroy M, Beaujouan JC, Petitet F, Torrens Y, Glowinski J.

Brain Res. 1994 Jan 7;633(1-2):317-25.

PMID:
7511036
24.

A new selective bioassay for tachykinin NK3 receptors based on inositol monophosphate accumulation in the guinea pig ileum.

Petitet F, Saffroy M, Torrens Y, Glowinski J, Beaujouan JC.

Eur J Pharmacol. 1993 Oct 15;247(2):185-91.

PMID:
7506659
25.

Importance of the leucine side-chain to the spasmogenic activity and binding of substance P analogues.

Lavielle S, Chassaing G, Brunissen A, Rodriguez M, Martinez J, Convert O, Carruette A, Garret C, Petitet F, Saffroy M, et al.

Int J Pept Protein Res. 1993 Sep;42(3):270-7.

PMID:
7693605
26.

NK-1 tachykinin receptor in rat and guinea pig brains: pharmacological and autoradiographical evidence for a species difference.

Petitet F, Beaujouan JC, Saffroy M, Torrens Y, Fardin V, Glowinski J.

Peptides. 1993 May-Jun;14(3):551-9.

PMID:
8392722
27.

Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists.

Beaujouan JC, Heuillet E, Petitet F, Saffroy M, Torrens Y, Glowinski J.

Br J Pharmacol. 1993 Mar;108(3):793-800.

28.

The nonpeptide NK-2 antagonist SR 48968 is also a NK-3 antagonist in the guinea but not in the rat.

Petitet F, Beaujouan JC, Saffroy M, Torrens Y, Glowinski J.

Biochem Biophys Res Commun. 1993 Feb 26;191(1):180-7.

PMID:
7680554
29.

[Pro9]SP and [pGlu6, Pro9]SP(6-11) interact with two different receptors in the guinea-pig ileum as demonstrated with new SP antagonists.

Chassaing G, Lavielle S, Brunissen A, Carruette A, Garret C, Petitet F, Saffroy M, Beaujouan JC, Torrens Y, Glowinski J.

Neuropeptides. 1992 Oct;23(2):73-9.

PMID:
1280787
30.

[A new tachykinin receptor revealed by substance P analogues in the guinea pig ileum].

Petitet F, Beaujouan JC, Saffroy M, Torrens Y, Lavielle S, Chassaing G, Loeuillet D, Glowinski J.

C R Acad Sci III. 1992 Mar 26;314(7):299-303. French.

PMID:
1285414
31.

Possible existence of a new tachykinin receptor subtype in the guinea pig ileum.

Petitet F, Saffroy M, Torrens Y, Lavielle S, Chassaing G, Loeuillet D, Glowinski J, Beaujouan JC.

Peptides. 1992 Mar-Apr;13(2):383-8.

PMID:
1384010
32.

Synergistic regulation of cytosolic Ca2+ concentration in mouse astrocytes by NK1 tachykinin and adenosine agonists.

Delumeau JC, Petitet F, Cordier J, Glowinski J, Prémont J.

J Neurochem. 1991 Dec;57(6):2026-35.

PMID:
1719134
33.

NK-1 receptors are the only class of tachykinin receptors found on mouse cortical astrocytes.

Beaujouan JC, Teutsch B, Saffroy M, Petitet F, Torrens Y, Glowinski J.

Peptides. 1991 Jul-Aug;12(4):813-20.

PMID:
1724079
34.

Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay).

Chassaing G, Lavielle S, Loeuillet D, Robilliard P, Carruette A, Garret C, Beaujouan JC, Saffroy M, Petitet F, Torrens Y, et al.

Neuropeptides. 1991 Jun;19(2):91-5.

PMID:
1658676
35.

Further demonstration that [Pro9]-substance P is a potent and selective ligand of NK-1 tachykinin receptors.

Petitet F, Beaujouan JC, Saffroy M, Torrens Y, Chassaing G, Lavielle S, Besseyre J, Garret C, Carruette A, Glowinski J.

J Neurochem. 1991 Mar;56(3):879-89.

PMID:
1704425
36.

Evoked release of acetylcholine in the rat striatum by stimulation of tachykinin NK-1 receptors.

Petitet F, Glowinski J, Beaujouan JC.

Eur J Pharmacol. 1991 Jan 3;192(1):203-4. No abstract available.

PMID:
1645676
37.

Selective agonists of tachykinin binding sites.

Lavielle S, Chassaing G, Loeuillet D, Convert O, Torrens Y, Beaujouan JC, Saffroy M, Petitet F, Bergström L, Glowinski J.

Fundam Clin Pharmacol. 1990;4(3):257-68. Review.

PMID:
2165464
38.

Neuropeptide K, scyliorhinin I and II: new tools in the tachykinin receptor field.

Beaujouan JC, Saffroy M, Petitet F, Torrens Y, Glowinski J.

Eur J Pharmacol. 1988 Jul 7;151(2):353-4. No abstract available.

PMID:
2844560

Supplemental Content

Loading ...
Support Center